Hyperbaric oxygen therapy (HBOT) is not one therapy. It is a pressure-based treatment where the pressure, the gas delivered, and the chamber engineering determine what physiology actually happens inside the body. A soft-shell inflatable chamber operating at 1.3 ATA on ambient air and a rigid medical-grade monoplace chamber operating at 2.5 ATA on 100% oxygen are different clinical tools. They are marketed under the same umbrella term — HBOT — and that marketing consistency hides a meaningful gap in output.
This article breaks down the difference in plain terms: pressure effects on dissolved oxygen (the physics), FDA clearance and evidence base (the medicine), safety engineering (the operations), and cost (the business). The goal is to help patients ask the three questions that separate a medical-grade program from a wellness chamber.
Mild HBOT uses soft-shell chambers at ~1.3 ATA with ambient air. Medical-grade HBOT uses rigid monoplace chambers at 2.0–2.5 ATA with 100% oxygen. FDA-approved clinical indications require the higher pressures. Research on long COVID, wound healing, and radiation injury is based on medical-grade protocols. Mild HBOT has not demonstrated equivalent outcomes for most claimed indications. TrufaMED operates a medical-grade rigid chamber in a Joint Commission-accredited clinical setting in Miami Beach.
Hyperbaric medicine is a Henry's Law application. Henry's Law states that the amount of a gas that dissolves into a liquid is proportional to the partial pressure of that gas above the liquid. Double the partial pressure of oxygen over blood plasma, and — at steady state — roughly double the amount of oxygen that dissolves into the plasma.
At normal atmospheric pressure (1.0 ATA) breathing ambient air (21% oxygen), plasma dissolved oxygen is trivial. Most oxygen delivery to tissue happens via hemoglobin. Breathing supplemental oxygen at the same pressure raises dissolved oxygen modestly. But at 2.0 ATA on 100% oxygen, dissolved plasma oxygen rises enough that tissue can be oxygenated through plasma alone — independent of hemoglobin. That is the physiologic state in which the documented tissue-level effects of HBOT become reproducible: mitochondrial biogenesis, angiogenesis, anti-inflammatory signaling, fibroblast and osteoblast activity.
At 1.3 ATA on ambient air — typical soft-shell mild HBOT — the change in dissolved plasma oxygen is a fraction of what medical-grade pressures produce. This is not a marketing opinion. It is the mathematics of gas solubility.
Atmospheric pressure absolute (ATA) is a practical way to describe chamber pressure in terms of what a diver would experience at depth:
The pressure difference between 1.3 and 2.0 ATA sounds small as a number. In terms of dissolved oxygen delivery — the clinical endpoint that most HBOT effects hinge on — it is the difference between a wellness experience and a medical intervention.
The U.S. FDA recognizes a specific list of clinical indications for which HBOT is an approved, sometimes reimbursable, treatment. The list is maintained by the Undersea and Hyperbaric Medical Society (UHMS) and adopted by CMS. Approved indications include:
Every one of these indications has published treatment protocols that specify pressure between 2.0 and 3.0 ATA on 100% oxygen in a medical-grade chamber. None of them has a protocol for 1.3 ATA soft-shell chambers. For insurance coverage specifics on these indications, see the cost and coverage overview.
For off-label indications — long COVID, traumatic brain injury recovery, athletic recovery, cosmetic anti-aging, cognitive optimization — the clinical research literature is almost entirely built on medical-grade protocols. The 2022 Tel Aviv long COVID RCT used 2.0 ATA. Published TBI research used 1.5 to 2.4 ATA. Wound healing literature uses 2.0 to 2.5 ATA. Athletic recovery studies use 2.0 ATA or higher.
The published evidence specifically for 1.3 ATA soft-shell chambers is comparatively thin and, for most claimed indications, absent. A patient paying for mild HBOT for a specific clinical outcome is paying based on a literature that does not exist for that pressure.
This is not to say mild HBOT is useless for everyone. For general wellness experiences where the evidence base itself is thin, it is a lower-cost option. For anything where someone has read research suggesting HBOT may help — the research almost certainly was conducted in a medical-grade chamber.
Rigid monoplace medical chambers are pressure vessels engineered to ASME PVHO standards (Pressure Vessels for Human Occupancy). They are designed for 100% oxygen at elevated pressure, which is a fire-safety concern requiring specific protocols:
Soft-shell inflatable chambers typically use ambient air or mildly enriched air. The fire risk is lower, the training threshold is lower, and the regulatory category is different. A soft chamber is easier to operate because the therapeutic output is also substantially lower.
| Feature | Mild HBOT (Soft Chamber) | Medical-Grade HBOT (Rigid Monoplace) |
|---|---|---|
| Max pressure | ~1.3 ATA | 2.0–2.5+ ATA |
| Gas delivered | Ambient air or mildly enriched | 100% medical-grade oxygen |
| Chamber material | Inflatable soft-shell | Rigid acrylic/steel, ASME PVHO |
| FDA-approved indications | Not cleared for clinical indications | Cleared for 14+ indications |
| Research protocol match | No match to most published trials | Matches research protocols |
| Fire-risk protocol | Lower — ambient air | High — 100% O2 protocols required |
| Typical session cost | Lower per session | Higher per session — reflects chamber, oxygen, staffing |
| Physician supervision | Often self-directed or tech-run | Physician-led, clinical setting |
Per-session cost for mild HBOT is typically lower because the operating cost profile is lower: soft chambers cost less to acquire, ambient air costs nothing, and staffing requirements are lighter. Medical-grade HBOT pricing reflects rigid chamber capital cost, ongoing clinical oxygen supply, physician-led programming, Joint Commission-accredited environment, and staff training. For a detailed breakdown of TrufaMED's HBOT pricing, see HBOT cost in Miami Beach.
The cost difference aligns with the output difference. A patient weighing cost-per-session in isolation may be comparing two different clinical tools.
For the research-supported long COVID protocol specifically, see HBOT for long COVID recovery. For athletic recovery, see HBOT recovery for athletes.
The answers to those three questions take 30 seconds and clarify exactly what product is being purchased.
TrufaMED in Surfside operates a rigid medical-grade monoplace chamber rated to 2.5 ATA. Every session is physician-ordered and staff-monitored. Sessions take place inside a Joint Commission-accredited urgent care and concierge medicine practice — Florida's only Joint Commission-accredited urgent care. Medical-grade oxygen is supplied to research-matching pressures. Fire-safety and emergency protocols are documented, current, and drilled.
TrufaMED does not operate a soft-shell mild HBOT chamber. The program is exclusively medical-grade, because that is where the clinical evidence lives. For full service detail, see hyperbaric oxygen therapy in Miami and HBOT benefits explained.
A physician-led consultation takes 30 minutes and tells you exactly whether medical-grade HBOT is aligned with what you are trying to accomplish.
Contact Our TeamMild HBOT, usually delivered in soft-shell inflatable chambers, operates at approximately 1.3 ATA (equivalent to about 10 feet underwater) with ambient or mildly enriched air. Medical-grade rigid monoplace chambers deliver 100% oxygen at 2.0 to 2.5 ATA (equivalent to 33 to 50 feet underwater). The clinical effect on dissolved plasma oxygen is substantially different at those pressures.
No. The pressure-mediated effects on dissolved oxygen, angiogenesis, mitochondrial biogenesis, and most indications studied in the peer-reviewed literature are based on medical-grade chamber protocols at 2.0 ATA or higher. Mild HBOT has not consistently demonstrated equivalent clinical outcomes for most claimed indications.
FDA-cleared clinical indications — air embolism, carbon monoxide poisoning, diabetic foot ulcer meeting criteria, osteoradionecrosis, delayed radiation injury, and others — require treatment in a medical-grade chamber at approved pressures. Mild HBOT chambers are not cleared for these indications.
Soft-shell chambers are marketed for general wellness use. The pressure they deliver is modest enough to be used unsupervised in some contexts, and they are not classified as medical devices for clinical indications. Marketing claims made for home soft chambers frequently overstate the available evidence.
Henry's Law describes the relationship between gas pressure and how much of that gas dissolves into a liquid. In HBOT, higher chamber pressure drives more oxygen into dissolved plasma — oxygen that travels independently of hemoglobin. At 2.0 ATA on 100% oxygen, plasma oxygen rises enough to supply tissue even without hemoglobin delivery. At 1.3 ATA on ambient air, the change is minimal.
Yes, when operated under proper protocols. Rigid monoplace chambers require specific fire-safety, grounding, and emergency-depressurization protocols because 100% oxygen environments are fire risks. Joint Commission-accredited programs maintain documented training and safety practices. TrufaMED meets those standards.
Lower capital cost for the operator, lower oxygen cost (ambient air vs. 100% medical oxygen), lower staffing requirement (less specialized training). The session price reflects that — and, in the places where evidence matters most, the clinical output reflects it too.
For general wellness and cases where the evidence base is itself thin, patients sometimes choose mild HBOT for cost reasons. For FDA-approved indications, long COVID research-matched protocols, post-surgery or wound healing, radiation injury, or any situation where the research literature specifies 2.0 ATA or higher — mild HBOT will not replicate the protocol.
Three questions: What pressure (ATA) does this chamber operate at? What gas is delivered (100% oxygen or ambient air)? Is it FDA-cleared for my specific indication? The answers differentiate a medical-grade program from a wellness chamber immediately.
TrufaMED operates a rigid medical-grade monoplace chamber at pressures up to 2.5 ATA under physician supervision in a Joint Commission-accredited clinical environment. We do not operate soft-shell mild HBOT.
TrufaMED Urgent Care and Concierge Medicine, 9445 Harding Avenue, Surfside, FL 33154. Joint Commission accredited. Rigid medical-grade monoplace chamber to 2.5 ATA. Mon-Fri 9 AM-9 PM, Sat 11 AM-11 PM, Sun 12 PM-8 PM. Our staff. Concierge services.
Serving These Areas
Copyright © 2026 TrufaMED Urgent Care
